已发表论文

miR-183-5p  通过增加有氧糖酵解促进 HCC 迁移/侵袭

 

Authors Niu Y, Liu F, Wang X, Chang Y, Song Y, Chu H, Bao S, Chen C

Received 28 January 2021

Accepted for publication 24 April 2021

Published 4 June 2021 Volume 2021:14 Pages 3649—3658

DOI https://doi.org/10.2147/OTT.S304117

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Prof. Dr. Nicola Silvestris

Background: The mortality and morbidity of hepatocellular carcinoma (HCC) are still unacceptably high, despite decades of extensive studies. Aerobic glycolysis is a hallmark of cancer metabolism, closely relating to invasion and metastasis of HCC. MicroRNAs (miRNAs) are involved in the regulation of aerobic glycolysis. miR-183-5p , an oncogenic miRNA, is highly expressed in HCC, but the regulatory mechanism of miR-183-5p  in migration, invasion and aerobic glycolysis in HCC remains unclear.
Purpose: To elucidate whether miR-183-5p  affects aerobic glycolysis to regulate the migration and invasion of HCC, and to explore its regulatory mechanism.
Methods: We attempted to observe the effects of miR-183-5p  on the migration and invasion of HepG2 cells by a wound-healing assay and Transwell assays. The effect of miR-183-5p  on glycolysis was determined by glucose uptake and lactate generation. Western blot and qPCR were used to detect the relevant proteins and miRNA expression.
Results: Our results show that miR-183-5p  promoted migration and invasion, enhanced glycolysis via increasing glucose uptake and lactate generation, and up-regulated glycolysis-related gene (PKM2 HK2 LDHA GLUT1 ) expression in HepG2 cells. Further experiments indicated that miR-183-5p  could decrease PTEN expression, but increased Akt, p-Akt and mTOR expression in HepG2 cells.
Conclusion: These findings suggest that miR-183-5p  may promote HCC migration and invasion via increasing aerobic glycolysis through targeting PTEN and then activating Akt/mTOR signaling.
Keywords: miR-183-5p , aerobic glycolysis, migration, invasion, PTEN/Akt/mTOR, hepatocellular carcinoma